First human test: new drug copy compared to original
NCT ID NCT06262477
Summary
This early-stage study aimed to see if a new drug called BIIB800 behaves similarly in the body to an existing drug, Actemra. It involved 300 healthy male volunteers who received a single injection of one of the drugs. Researchers measured drug levels in the blood, safety, and the body's immune response to understand if the two drugs are comparable.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit Inc.
Daytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit Inc.
Dallas, Texas, 75247, United States
-
Fortrea Clinical Research Unit Inc.
Madison, Wisconsin, 53704, United States
-
Fortrea Clinical Research Unit Inc.
Leeds, West Yorkshire, LS2 9LH, United Kingdom
Conditions
Explore the condition pages connected to this study.